People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zero Point Five Therapeutics, Inc. | — | Biotechnology | Series A | $11.5M | $15.7M | 2023 |
| TallyX, Inc. | — | Other Technology | Seed | $3.1M | $104.1M | 2019 |
Jodi Jahic at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jodi Jahic on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Susan Mason | 1 | 10 |
| Ben Auspitz | 1 | 9 |
| Joseph Amprey III | 1 | 1 |
| Qianqian Liang | 1 | 1 |
| Aditya Menon | 1 | 1 |
| Yean-whei Tseng | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.